Market Tracker

07/25 6:05pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7088
Data as of Jul 25
 -0.0017 / -0.24%
Today’s Change
0.36
Today|||52-Week Range
1.85
+38.98%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.71
Today’s open0.72
Day’s range0.70 - 0.73
Volume560,986
Average volume (3 months)1,982,798
Market cap$125.2M
Dividend yield--
Data as of 4:00pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-66.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.24

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...+0.22+3.35%
MDGNMedgenics Inc-0.02-0.30%
ARGSArgos Therapeutics I...-0.08-1.22%
CORICorium International...+0.05+0.72%
Data as of 4:01pm ET, 07/25/2014

Financials

Next reporting dateSeptember 3, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts